Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004568 · ClinicalTrials.gov registry record

Study of Inherited Neurological Disorders

A clinical trial of Motor Neuron Disease and Muscular Dystrophy, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Recruiting
Registry status
3,500
Enrollment target
2
Study locations

NCT00004568: Recruiting study of Motor Neuron Disease and Muscular Dystrophy, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00004568 is a study of Motor Neuron Disease and Muscular Dystrophy that is actively recruiting participants, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 3,500 participants, above the 324-participant average among 17 other Motor Neuron Disease trials with a reported enrollment target (980% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004568, a study of Motor Neuron Disease and Muscular Dystrophy, is actively recruiting participants, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

RECRUITING
Registry status
3,500 participants
Enrollment target
2
Study locations

Study Summary

This study is designed to learn more about the natural history of inherited neurological disorders and the role of heredity in their development. It will examine the genetics, symptoms, disease progression, treatment, and psychological and behavioral impact of diseases in the following categories: hereditary peripheral neuropathies; hereditary myopathies; muscular dystrophies; hereditary motor neuron disorders; mitochondrial myopathies; hereditary neurocognitive disorders; inherited neurological disorders without known diagnosis; and others. Many of these diseases, which affect the brain, spinal cord, muscles, and nerves, are rare and poorly understood. Children and adults of all ages with various inherited neurological disorders may be eligible for this study. Participants will undergo a detailed medical and family history, and a family tree will be drawn. They will also have a physical and neurological examination that may include blood test and urine tests, an EEG (brain wave recordings), psychological tests, and speech and language and rehabilitation evaluations. A blood sample or skin biopsy may be taken for genetic testing. Depending on the individual patient s symptoms, imaging tests such as X-rays, CT or MRI scans and muscle and nerve testing may also be done. Information from this study may provide a better understanding of the genetic underpinnings of these disorders, contributing to improved diagnosis, treatment, and genetic counseling, and perhaps leading to additional studies in these areas.

Primary Outcome

The primary objective of this protocol is to provide a resource of participants for enrollment into new research protocols throughout the NGB and other NIH laboratories. Evaluating and diagnosing participants will allow the NGB specialists to maintain their expertise and gain additional knowledge of the course of various neurological disorders. The information obtained will allow for the evaluation and diagnosis of the studied neurological diseases. This understanding may lead to ideas for futur

Conditions Studied

Motor Neuron Disease Muscular Dystrophy Muscular Disease Peripheral Nervous System Disease

Study Locations (2)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Other

  • University of Mali - Bamako

Trial Details

FieldValue
Enrollment Target 3,500 participants
Start Date 2000-02-18
National Institute of Neurological Disorders and Stroke (NINDS)

567 total trials

What NCT00004568 shows while recruiting

NCT00004568 is an observational study that tracks outcomes without assigning an intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 324-participant average among 17 other Motor Neuron Disease trials with a reported enrollment target (980% higher).

The record links to 4 conditions, with Motor Neuron Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00004568 reports a single indexed study location in Maryland, Other.

Frequently Asked Questions

What is clinical trial NCT00004568 about?

NCT00004568 is a clinical study titled "Study of Inherited Neurological Disorders". This study is designed to learn more about the natural history of inherited neurological disorders and the role of heredity in their development. It will examine the genetics, symptoms, disease progression, treatment, and psychological and behavioral impact of diseases in the following categories: h...

What is the current status of trial NCT00004568?

This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 2000-02-18.

What conditions does trial NCT00004568 study?

This clinical trial studies the following conditions: Motor Neuron Disease, Muscular Dystrophy, Muscular Disease, Peripheral Nervous System Disease.

Who is sponsoring clinical trial NCT00004568?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004568 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Motor Neuron Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00004568's enrollment target sits among peer trials

3,500 1st of 17 higher than 17 of 17 other Motor Neuron Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Motor Neuron Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00260559 · 3,500 participants

    Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

  • NCT01612949 · 3,500 participants

    Facial Analysis to Classify Difficult Intubation

  • NCT02398786 · 3,500 participants

    Myotonic Dystrophy Family Registry

  • NCT03486873 · 3,500 participants · Phase 3

    Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT00004568

Source: ClinicalTrials.gov NCT00004568, the US trial registry maintained by the National Library of Medicine. NCT00004568 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.